POMDOCTOR Ltd (POM)

CN — Healthcare Sector
Peers: SIBN  PACB  AIRS  INNV  OFIX  AVXL  ERAS  AQST  FLGT  CTMX 

Automate Your Wheel Strategy on POM

With Tiblio's Option Bot, you can configure your own wheel strategy including POM - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol POM
  • Rev/Share 2.8921
  • Book/Share -17.6853
  • PB -0.0851
  • Debt/Equity -0.1949
  • CurrentRatio 0.2093
  • ROIC 0.4403

 

  • MktCap 173840038.108
  • FreeCF/Share -0.1365
  • PFCF -10.7517
  • PE -1.3431
  • Debt/Assets 9.542
  • DivYield 0
  • ROE 0.0654

 

  • Rating
  • Score
  • Recommendation
  • P/E Score
  • DCF Score
  • P/B Score
  • D/E Score

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies
POM
Published: January 16, 2026 by: PRNewsWire
Sentiment: Neutral

GUANGZHOU, China, Jan. 16, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced significant progress in its strategic collaboration with leading domestic pharmaceutical companies to accelerate the growth of its internet hospital business. The Company expects these partnerships to become a core component of its long-term strategy to expand online hospital operations and enhance overall profitability.

Read More
image for news POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies

About POMDOCTOR Ltd (POM)

  • IPO Date 2025-10-08
  • Website https://www.7lk.com
  • Industry Medical - Pharmaceuticals
  • CEO Zhenyang Shi
  • Employees 156

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company's business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.